385 related articles for article (PubMed ID: 12783249)
21. A clinicopathologic and immunohistochemical analysis of 53 cases of medulloblastoma with emphasis on synaptophysin expression.
Coffin CM; Braun JT; Wick MR; Dehner LP
Mod Pathol; 1990 Mar; 3(2):164-70. PubMed ID: 2109316
[TBL] [Abstract][Full Text] [Related]
22. Expression of alpha-synuclein in different brain parts of adult and aged rats.
Adamczyk A; Solecka J; Strosznajder JB
J Physiol Pharmacol; 2005 Mar; 56(1):29-37. PubMed ID: 15795473
[TBL] [Abstract][Full Text] [Related]
23. Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas.
Geiger KD; Stoldt P; Schlote W; Derouiche A
Am J Pathol; 2000 Dec; 157(6):1785-93. PubMed ID: 11106550
[TBL] [Abstract][Full Text] [Related]
24. Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of gamma-synuclein, alpha-synuclein and double alpha/gamma-synuclein null mutant mice.
Robertson DC; Schmidt O; Ninkina N; Jones PA; Sharkey J; Buchman VL
J Neurochem; 2004 Jun; 89(5):1126-36. PubMed ID: 15147505
[TBL] [Abstract][Full Text] [Related]
25. Pick's disease: alpha- and beta-synuclein-immunoreactive Pick bodies in the dentate gyrus.
Mori F; Hayashi S; Yamagishi S; Yoshimoto M; Yagihashi S; Takahashi H; Wakabayashi K
Acta Neuropathol; 2002 Nov; 104(5):455-61. PubMed ID: 12410393
[TBL] [Abstract][Full Text] [Related]
26. Medulloblastoma.
Katsetos CD; Burger PC
Semin Diagn Pathol; 1994 May; 11(2):85-97. PubMed ID: 7809510
[TBL] [Abstract][Full Text] [Related]
27. Prominent perikaryal expression of alpha- and beta-synuclein in neurons of dorsal root ganglion and in medullary neurons.
Giasson BI; Duda JE; Forman MS; Lee VM; Trojanowski JQ
Exp Neurol; 2001 Dec; 172(2):354-62. PubMed ID: 11716559
[TBL] [Abstract][Full Text] [Related]
28. Stimulation of estrogen receptor signaling by gamma synuclein.
Jiang Y; Liu YE; Lu A; Gupta A; Goldberg ID; Liu J; Shi YE
Cancer Res; 2003 Jul; 63(14):3899-903. PubMed ID: 12873981
[TBL] [Abstract][Full Text] [Related]
29. Alpha-synuclein expression in the developing human brain.
Raghavan R; Kruijff Ld; Sterrenburg MD; Rogers BB; Hladik CL; White CL
Pediatr Dev Pathol; 2004; 7(5):506-16. PubMed ID: 15547775
[TBL] [Abstract][Full Text] [Related]
30. [Synucleins--to have or not to have].
Ninkina NN; Bukhman VL
Genetika; 2000 Nov; 36(11):1487-91. PubMed ID: 11094765
[TBL] [Abstract][Full Text] [Related]
31. Expression of survivin, an inhibitor of apoptosis protein, in tumors of the nervous system.
Sasaki T; Lopes MB; Hankins GR; Helm GA
Acta Neuropathol; 2002 Jul; 104(1):105-9. PubMed ID: 12070671
[TBL] [Abstract][Full Text] [Related]
32. Alpha-internexin expression in medulloblastomas and atypical teratoid-rhabdoid tumors.
Kaya B; Mena H; Miettinen M; Rushing EJ
Clin Neuropathol; 2003; 22(5):215-21. PubMed ID: 14531545
[TBL] [Abstract][Full Text] [Related]
33. Identification of novel biomarkers in pediatric primitive neuroectodermal tumors and ependymomas by proteome-wide analysis.
de Bont JM; den Boer ML; Kros JM; Passier MM; Reddingius RE; Smitt PA; Luider TM; Pieters R
J Neuropathol Exp Neurol; 2007 Jun; 66(6):505-16. PubMed ID: 17549010
[TBL] [Abstract][Full Text] [Related]
34. Use of monoclonal antibodies to glial fibrillary acidic protein in the cytologic diagnosis of brain tumors.
Chen Y; Zhang YX
Acta Cytol; 1989; 33(6):922-8. PubMed ID: 2588925
[TBL] [Abstract][Full Text] [Related]
35. Neuropathological spectrum of synucleinopathies.
Jellinger KA
Mov Disord; 2003 Sep; 18 Suppl 6():S2-12. PubMed ID: 14502650
[TBL] [Abstract][Full Text] [Related]
36. Genomic organization and expression of the human beta-synuclein gene (SNCB).
Lavedan C; Leroy E; Torres R; Dehejia A; Dutra A; Buchholtz S; Nussbaum RL; Polymeropoulos MH
Genomics; 1998 Nov; 54(1):173-5. PubMed ID: 9806846
[TBL] [Abstract][Full Text] [Related]
37. Cyclooxygenase-2 (COX-2) overexpression in childhood brain tumors.
Bodey B; Siegel SE; Kaiser HE
In Vivo; 2006; 20(4):519-25. PubMed ID: 16900783
[TBL] [Abstract][Full Text] [Related]
38. BDNF is induced by wild-type alpha-synuclein but not by the two mutants, A30P or A53T, in glioma cell line.
Kohno R; Sawada H; Kawamoto Y; Uemura K; Shibasaki H; Shimohama S
Biochem Biophys Res Commun; 2004 May; 318(1):113-8. PubMed ID: 15110760
[TBL] [Abstract][Full Text] [Related]
39. Glial differentiation predicts poor clinical outcome in primitive neuroectodermal brain tumors.
Janss AJ; Yachnis AT; Silber JH; Trojanowski JQ; Lee VM; Sutton LN; Perilongo G; Rorke LB; Phillips PC
Ann Neurol; 1996 Apr; 39(4):481-9. PubMed ID: 8619526
[TBL] [Abstract][Full Text] [Related]
40. [Glial fibrillary acidic protein and central nervous system tumors. Immunohistochemical study of a series of 207 cases. 2: Medulloblastomas. Hemangioblastomas. Other tumors. Discussion].
Pasquier B; Lachard A; Pasquier D; Couderc P; Delpech B; Courel MN
Ann Pathol; 1983 Sep; 3(3):203-11. PubMed ID: 6354202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
